Biotest Aktiengesellschaft

BATS-CHIXE:BIO3D Stock Report

Market Cap: €1.5b

Biotest Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BIO3D?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,001,0972.53%
Public Companies1,250,2983.16%
Private Companies17,783,77644.9%
General Public19,536,28149.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 17 shareholders own 50.63% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
44.9%
Tiancheng International Investment Limited
17,783,776€656.2m0%no data
3.16%
Grifols, S.A.
1,250,298€46.1m0%no data
1.87%
Polygon Global Partners LLP
739,986€27.3m0%7.43%
0.26%
Ersel Asset Management SGR S.p.A.
102,344€3.8m0%0.45%
0.12%
Knoesel & Ronge VermÖGensverwaltung Gmbh & Co. Kg
46,000€1.7m0%1.95%
0.076%
Bantleon Bank AG, Asset Management Arm
30,000€1.1m0%0.58%
0.063%
Investmentaktiengesellschaft FÜR Langfristige Investoren Tgv
25,000€922.5k0%0.04%
0.062%
FPS Vermoegensverwaltung GmbH
24,614€908.2k0%1.91%
0.034%
UBS Asset Management AG
13,267€489.6k0%no data
0.021%
Altrafin Advisory AG
8,500€313.6k0%0.08%
0.013%
Arvernus Capital Ltd.
5,187€191.4k0%2.9%
0.0059%
SIGNAL IDUNA Asset Management GmbH
2,348€86.6k0%0.01%
0.0036%
Casa4Funds SA
1,405€51.8k0%0.06%
0.0032%
VM Vermögens-Management GmbH
1,272€46.9k0%0.07%
0.0013%
Via Am
500€18.4k0%0.01%
0.00089%
State Street Global Advisors, Inc.
352€13.0k9.32%no data
0.00081%
Norges Bank Investment Management
322€11.8k0%no data